Literature DB >> 18284110

Patient autonomy and relatives' right to know genetic information.

Roy Gilbar1.   

Abstract

One of the most difficult issues doctors face is a conflict between their professional duties. Such a conflict may arise when doctors know that information has implications not only for patients but also for family members but their duty of confidentiality prevents them from disclosing it. A comparative analysis of English and Israeli medical law reveals that the doctors' duty is based on two principles: a liberal perception of patient autonomy and an overriding utilitarian principle of prevention of harm. However, socio-medical research indicates that these principles do not entirely reflect the views of patients and doctors and are too narrow to deal with the complex situations in practice. Thus, it is argued that the doctor's legal duty of confidentiality should be reconsidered and qualified when it concerns the family. It is suggested that if medical law seeks to recognize the various interests family members have in genetic information then we should consider a different approach, founded on a relational interpretation of autonomy and communitarian notions of solidarity and moral responsibility. This approach perceives confidentiality and privacy as embracing the family unit, based on the view that close relatives are not entirely outside the private sphere of the individual but rather are integral to his or her identity. Thus, to the utilitarian mechanism available in medical law this approach adds a social criterion: The effect any decision (to disclose or not to disclose) will have on the familial relationship and on the dynamics of the particular family. This will provide a more flexible and workable alternative for doctors to resolve familial tensions over access to genetic information.

Entities:  

Mesh:

Year:  2007        PMID: 18284110

Source DB:  PubMed          Journal:  Med Law        ISSN: 0723-1393


  4 in total

Review 1.  Genotype-phenotype databases: challenges and solutions for the post-genomic era.

Authors:  Gudmundur A Thorisson; Juha Muilu; Anthony J Brookes
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

2.  Genetic testing of children for familial cancers: a comparative legal perspective on consent, communication of information and confidentiality.

Authors:  Roy Gilbar
Journal:  Fam Cancer       Date:  2009-07-17       Impact factor: 2.375

3.  Implementation of the CDC translational informatics platform--from genetic variants to the national Swedish Rheumatology Quality Register.

Authors:  Imad Abugessaisa; David Gomez-Cabrero; Omri Snir; Staffan Lindblad; Lars Klareskog; Vivianne Malmström; Jesper Tegnér
Journal:  J Transl Med       Date:  2013-04-02       Impact factor: 5.531

4.  Shared decision-making in Israel: status, barriers, and recommendations.

Authors:  Talya Miron-Shatz; Ofra Golan; Mayer Brezis; Gil Siegal; Glen M Doniger
Journal:  Isr J Health Policy Res       Date:  2012-01-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.